4.6 Review

A meta-analysis of prevalence rates and moderating factors for cancer-related post-traumatic stress disorder

Journal

PSYCHO-ONCOLOGY
Volume 24, Issue 4, Pages 371-381

Publisher

WILEY
DOI: 10.1002/pon.3654

Keywords

cancer; oncology; PTSD; prevalence; meta-analysis; DSM-5

Funding

  1. Bournemouth University
  2. Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust

Ask authors/readers for more resources

ObjectiveSystematic reviews highlight a broad range of cancer-related post-traumatic stress disorder (CR-PTSD) prevalence estimates in cancer survivors. This meta-analysis was conducted to provide a prevalence estimate of significant CR-PTSD symptoms and full diagnoses to facilitate the psychological aftercare of cancer survivors. MethodsA systematic literature search was conducted for studies using samples of cancer survivors by using validated clinical interviews and questionnaires to assess the prevalence of CR-PTSD (k=25, n=4189). Prevalence estimates were calculated for each assessment method using random-effects meta-analysis. Mixed-effects meta-regression and categorical analyses were used to investigate study-level moderator effects. ResultsStudies using the PTSD ChecklistCivilian Version yielded lower event rates using cut-off [7.3%, 95% confidence intervals (CI)=4.5-11.7, k=10] than symptom cluster (11.2%, 95% CI=8.7-14.4, k=9). Studies using the Structured Clinical Interview for Diagnostic and Statistical Manual, Fourth Edition (SCID), yielded low rates for lifetime (15.3%, 95% CI=9.1-25, k=5) and current CR-PTSD (5.1%, 95% CI=2.8-8.9, k=9). Between-study heterogeneity was substantial (I-2=54-87%). Studies with advanced-stage samples yielded significantly higher rates with PTSD ChecklistCivilian Version cluster scoring (p=0.05), and when assessing current CR-PTSD on the SCID (p=0.05). The effect of mean age on current PTSD prevalence met significance on the SCID (p=0.05). SCID lifetime prevalence rates decreased with time post-treatment (R-2=0.56, p<0.05). DiscussionThe cancer experience is sufficiently traumatic to induce PTSD in a minority of cancer survivors. Post-hoc analyses suggest that those who are younger, are diagnosed with more advanced disease and recently completed treatment may be at greater risk of PTSD. More research is needed to investigate vulnerability factors for PTSD in cancer survivors. (c) 2014 The Authors. Psycho-Oncology published by John Wiley & Sons Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available